Autologous cell therapy - A new concept to eradicate inhibitors in haemophilia
Haemophilia
.
2022 Nov;28(6):e259-e261.
doi: 10.1111/hae.14663.
Epub 2022 Sep 19.
Authors
Hanjing Xie
1
2
,
Rolf Ljung
3
4
,
Jan Astermark
5
6
,
Terese Hylander
1
Affiliations
1
Idogen AB, Medicon Village, Scheelevägen 2, Lund, Sweden.
2
Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
3
Department of Clinical Sciences, Lund University, Lund, Sweden.
4
Department of Paediatrics, Lund University, Lund, Sweden.
5
Department of Translational Medicine, Lund University, Lund, Sweden.
6
Department for Hematology, Oncology and Radiation Physics, Skane University Hospital, Malmö, Sweden.
PMID:
36122904
PMCID:
PMC9826384
DOI:
10.1111/hae.14663
No abstract available
Publication types
Letter
MeSH terms
Cell- and Tissue-Based Therapy
Factor VIII
Hemophilia A* / drug therapy
Humans
Substances
Factor VIII